In brief
Key points
- ✓Months rather than days
- ✓Early dots may be subtle
- ✓Regular review
- ✓Stop rules matter
Allow a fair assessment period
Phototherapy and topical plans need enough consistent use to judge response, while avoiding indefinite treatment without meaningful review.
Review more than colour
Clinicians also assess stability, new patches, adverse effects, burden, adherence and quality of life when deciding whether to continue or change course.
Editorial basis: current AWMF S2k guideline on the diagnosis and treatment of vitiligo, register 013-093, version 2.0 dated 27 July 2026. Reviewed on 2 September 2026.
Commercial links are limited to approved IDEALDERM product information.